Supported by Shanghai Hospital Development Center Foundation,No.SHDC2022CRS033.
BACKGROUND Hepatocellular carcinoma(HCC)is one of the leading causes of death due to its complexity,heterogeneity,rapid metastasis and easy recurrence after surgical resection.We demonstrated that combination therapy ...
BACKGROUND While clinical guidelines recommend hepatocellular carcinoma(HCC)surveillance for at-risk individuals,reported surveillance rates in the United States and Europe remain disappointingly low.AIM To quantify H...
Supported by the National Key R&D Program of China,No.2016YFC0106604.
BACKGROUND In hepatocellular carcinoma(HCC),abnormal expression of multiple micro RNAs(miRNAs)has been shown to be involved in the malignant biological behavior of liver cancer.The vast majority of liver cancer cases ...
Supported by the College of Medicine Research Centre,Deanship of Scientific Research,King Saud University,Riyadh,Saudi Arabia
BACKGROUND Artificial intelligence,such as convolutional neural networks(CNNs),has been used in the interpretation of images and the diagnosis of hepatocellular cancer(HCC)and liver masses.CNN,a machine-learning algor...
BACKGROUND Hepatitis B virus,together with hepatitis C virus,has been recognized as the leading causes of hepatocellular carcinoma(HCC).Long non-coding RNAs(lncRNAs)have been suggested in increasing studies to be the ...
BACKGROUND Early diagnosis of hepatocellular carcinoma(HCC)is necessary to improve the prognosis of patients.However,the currently available tumor biomarkers are insufficient for the early detection of HCC.Acylcarniti...
BACKGROUND Circular RNAs(circRNAs)are a newly discovered class of endogenous noncoding RNAs that may have roles in cancer genesis and development.In the recent literature,dysregulated circRNAs have been extensively in...
Supported by the Ministry of Science and Technology,Taiwan,No.MOST 107-2314-B-002-217-MY3;National Taiwan University Hospital,Taiwan,No.NTUH 108-S4143
Hepatocellular carcinoma(HCC)is the fifth most common malignancy and the second leading cause of cancer mortality worldwide.The cornerstone to improving the prognosis of HCC patients has been the control of loco-regio...
BACKGROUND Many advanced hepatocellular carcinoma(HCC) patients are receiving sorafenib treatment. Sorafenib reportedly improves overall survival(OS) significantly in patients with HCC. Prediction of sorafenib respons...
Stereotactic body radiation therapy(SBRT) is an emerging treatment for hepatocellular carcinoma. This technique results in excellent local control rates with favorable toxicity profile despite being predominantly used...